Valuation: TransMedics Group, Inc.

Market Cap 2.46B 2.15B 1.99B 1.83B 3.48B 235B 3.54B 23.73B 9.32B 116B 9.24B 9.04B 398B P/E 2026 *
37.3x
P/E 2027 * 21.7x
Enterprise Value 2.5B 2.18B 2.01B 1.86B 3.53B 238B 3.59B 24.06B 9.45B 117B 9.37B 9.17B 403B EV / Sales 2026 *
3.4x
EV / Sales 2027 * 2.8x
Free-Float
96.57%
Yield 2026 *
-
Yield 2027 * -
1 day-1.33%
1 week+3.44%
Current month+7.24%
1 month-3.21%
3 months-37.52%
6 months-48.03%
Current year-41.45%
1 week 68.46
Extreme 68.46
73.3
1 month 64.84
Extreme 64.8448
80.72
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 1998-07-31
Director of Finance/CFO 55 2024-12-01
Chief Operating Officer 43 2023-02-01
Director TitleAgeSince
Director/Board Member 57 1998-07-31
Chairman 81 2010-12-31
Director/Board Member 78 2016-01-31
Date Insider Type Main position Quantity % Market Cap.
06-14Fiscal year

Director

48,194 0.1414%
05-19Free

Chairman

2,922 0.0086%
05-19Free

Director

2,922 0.0086%
Change 5-day change 1-year change 3-year change Capi.($)
-1.33%+3.44%-36.66%-17.91% 2.46B
+0.45%+0.69%+21.20%+1.50% 196B
-1.16%-4.51%-20.56%+19.96% 144B
+1.57%+0.57%-2.83%-16.25% 141B
-0.49%-0.82%-56.62%-14.64% 66.54B
+0.96%-2.29%+18.14%-0.25% 53.09B
+0.61%-1.09%-24.93%-30.81% 44.12B
+0.52%+2.75%+8.93%+13.34% 37.93B
-0.19%-0.75%+6.66%+42.84% 36.96B
-2.20%-2.75%-19.86%-6.01% 29.41B
Average -0.13%-0.56%-10.65%-0.82% 75.13B
Weighted average by Cap. +0.18%-1.01%-4.26%+0.53%

Financials

2026 *2027 *
Net sales 734M 642M 592M 547M 1.04B 69.96B 1.05B 7.07B 2.78B 34.47B 2.75B 2.69B 118B 869M 760M 701M 647M 1.23B 82.84B 1.25B 8.37B 3.29B 40.81B 3.26B 3.19B 140B
Net income 75.93M 66.41M 61.26M 56.58M 107M 7.24B 109M 732M 287M 3.57B 285M 279M 12.26B 132M 115M 106M 98.12M 186M 12.56B 189M 1.27B 498M 6.19B 494M 484M 21.27B
Net Debt 33.99M 29.73M 27.43M 25.33M 48.06M 3.24B 48.87M 328M 129M 1.6B 128M 125M 5.49B -30.91M -27.03M -24.94M -23.03M -43.7M -2.95B -44.43M -298M -117M -1.45B -116M -114M -4.99B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
26-07-10 US$71.23 -1.33% 455,656
26-07-09 US$72.19 +2.48% 637,530
26-07-08 US$70.44 -0.95% 863,155
26-07-07 US$71.12 -0.16% 754,297
26-07-06 US$71.23 +3.44% 946,322
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
71.23USD
Average target price
116.22USD
Spread / Average Target
+63.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock